ArticleJournal of translational medicine2013

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.

Bradford Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.